Workflow
万辰集团(300972) - 2021 Q2 - 季度财报
Wanchen GroupWanchen Group(SZ:300972)2021-08-29 16:00

Financial Performance - The company's operating revenue for the first half of 2021 was ¥165,479,069.82, a decrease of 23.50% compared to ¥216,300,504.86 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was -¥12,771,341.51, representing a decline of 125.17% from ¥50,737,800.72 in the previous year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥28,134,029.97, down 158.06% from ¥48,459,654.73 in the same period last year[21]. - The net cash flow from operating activities was ¥40,282,156.71, a decrease of 45.69% compared to ¥74,169,347.49 in the previous year[21]. - The basic earnings per share were -¥0.08, a decrease of 118.18% from ¥0.44 in the same period last year[21]. - The diluted earnings per share were also -¥0.08, reflecting the same decline of 118.18% from ¥0.44 in the previous year[21]. - The weighted average return on net assets was -3.24%, down 17.85% from 14.61% in the previous year[21]. - The company reported a net profit of -21,834,591 CNY for the first half of 2021, indicating a significant loss[80]. - The company reported a total revenue from sales of goods and services of CNY 164,207,153.27 for the first half of 2021, compared to CNY 215,047,803.50 in the same period of 2020[171]. Assets and Liabilities - The total assets at the end of the reporting period were ¥848,209,923.54, an increase of 28.85% from ¥658,267,502.95 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company increased by 53.87% to ¥616,485,381.35 from ¥400,653,822.86 at the end of the previous year[21]. - The company's total assets as of June 30, 2021, amounted to CNY 848,209,923.54, an increase from CNY 658,267,502.95 at the end of 2020, representing a growth of approximately 28.9%[157]. - Total liabilities decreased to CNY 231,724,542.19 from CNY 257,613,680.09, showing a reduction of about 10.1%[156]. - The company's equity attributable to shareholders rose to CNY 616,485,381.35 from CNY 400,653,822.86, marking an increase of approximately 54%[157]. Production and Operations - The company’s daily production capacity for edible mushrooms reached 255 tons, with 227 tons for enoki mushrooms and 28 tons for king oyster mushrooms[29]. - The company operates two production bases located in Fujian and Jiangsu, primarily serving East, South, and Central China, with some reach to Southwest, Northwest, North, and Northeast regions[29]. - The company has established two major production bases in Fujian Zhangzhou and Jiangsu Nanjing, which are strategically located in key consumption markets, enhancing brand influence and sales reach[49]. - The company has a strong scale advantage in the domestic factory-based edible mushroom production, with a centralized production model that reduces costs and enhances output stability[50]. - The company has diversified its product offerings, including four sub-varieties of edible mushrooms, which helps mitigate market risks associated with single product dependency[49]. Market Conditions - The decline in revenue and profit was primarily due to a decrease in the selling prices of the company's main products, enoki mushrooms and king oyster mushrooms[29]. - The edible mushroom market is experiencing seasonal price fluctuations, impacting the company's gross margin and overall performance[28]. - Seasonal fluctuations in sales prices of edible mushrooms can impact the company's gross margin and overall performance, with lower revenue typically seen in the first half of the year[81]. - The company faces risks from intensified market competition due to rapid capacity expansion in the edible mushroom industry, which could lead to significant price fluctuations[81]. Research and Development - The company is focused on the research and development of fresh edible mushrooms, responding to the growing market demand driven by health consciousness and consumption upgrades[28]. - The company has established a strong focus on R&D, collaborating with institutions like Fujian Agriculture and Forestry University to develop new technologies and products[41]. - The company is investing in technological innovation, particularly in strain selection and production process stability, to enhance its competitive edge[86]. - The company emphasizes the importance of food safety, utilizing fully automated processes for sowing, sterilization, and modular cultivation management to minimize contamination risks[88]. Financial Management - The company plans not to distribute cash dividends or issue bonus shares[7]. - The company has implemented a comprehensive management system for biological assets, ensuring accurate accounting and inventory control through monthly physical counts[42]. - The company has a strong focus on cost control and improving production efficiency to counteract potential declines in gross margin due to rising costs[85]. - The company has reported a significant increase in cash and cash equivalents, rising by 9,053.29% to ¥202,874,704.87 from ¥2,216,412.82[55]. Shareholder Information - The company issued 38.375 million shares at a price of RMB 7.19 per share, raising a total of RMB 275.91625 million, with a net amount of RMB 228.6029 million after deducting fees[67]. - The total number of ordinary shareholders at the end of the reporting period is 25,237[136]. - The largest shareholder, Fujian Huanxi Grass Agricultural Development Co., Ltd., holds 26.68% of the shares[136]. - The second largest shareholder, Zhangzhou Jinwancheng Investment Co., Ltd., holds 19.50% of the shares[136]. Compliance and Governance - The company has maintained a strong focus on corporate governance and compliance with relevant laws and regulations to ensure stable and healthy development[100]. - The company's half-year financial report has not been audited, indicating that the financial results are still subject to review[105]. - There have been no major litigation or arbitration matters reported during the period, reflecting a stable legal standing for the company[107].